Semibranch Registry - Retrospective
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Muenster
About this trial
The goal of this registry is to evaluate the semibranch in branched endovascular arotic repair, which is a new tool in endovascular branched aortic repair.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient has been treated with the semibranch stentgraft
Patient is over 18 years old
Disqualifiers
None
Trial population
Patients with pararenal or thoracoabdominal aortic pathology, who are treated with a endovascular semibranch stentgraft
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Semibranch CMD branched aortic stentgraft
DevicebEVAR with a custom made abdominal aortic multibranch, which incorporates the semibranch design
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Freedom from target vessel instability
Primary patency and freedom from stenosis of the semibranch
Time frame
30 days after intervention2
Mortality
Overall mortality rate during 30 days after intervention
Time frame
30 days after intervention3
Technical success
cannulation and stentgrafting ot the semibranches
Time frame
12 hours after interventionSecondary outcomes
1
Morbidity
Access site, bowel ischemia, kidney failure, paraplegia
Time frame
During follow up period (up to 3 years)2
Freedom of Endoleak type I and III
Abscence of endoleaks arising from the semibranch
Time frame
During follow up period (up to 3 years)3
Long term mortality
Overall mortality up to 3 years
Time frame
During follow up period (up to 3 years)4
Branch patency
Primary patency of all branches
Time frame
During follow up period (up to 3 years)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov